Menu
Back to Journals » Pharmacogenomics and Personalized Medicine » Volume 14
Association of CYP2B6 Genetic Variation with Efavirenz and Nevirapine Drug Resistance in HIV-1 Patients from Botswana [Corrigendum]
Authors Maseng MJ, Tawe L, Thami PK , Seatla KK , Moyo S , Martinelli A, Kasvosve I, Novitsky V, Essex M, Russo G , Gaseitsiwe S, Paganotti GM
Received 25 March 2021
Accepted for publication 25 March 2021
Published 31 March 2021 Volume 2021:14 Pages 395—396
Maseng MJ, Tawe L, Thami PK, et al. Pharmgenomics Pers Med. 2021;14:335–347.
The authors have advised that there is an error in Table 6 on page 342. The reference “39” in the third row for the References column should read “41”.
The authors apologize for this error.
© 2021 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.